{
  "symbol": "KYTX",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["Biotechnology sector", "Small market capitalization", "Clinical-stage development"],
    "riskScore": 7,
    "reason": "Kyverna Therapeutics operates in the biotech sector, which is prone to speculation, and has a small market cap, making it susceptible to retail-driven volatility."
  }
}